Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients
NCT02117518
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Type I Diabetes
Interventions
OTHER:
blood drawing
Sponsor
Migal Galilee Research Institute
Collaborators
[object Object]